AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Eveglip-M Tablet

Prescription Icon
Prescription Required

Marketer

Eleveton Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Eveglip-M Tablet

Diabex Duo tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes, mitigating the risk of severe diabetic complications like renal impairment and vision loss. It may also lessen the likelihood of cardiovascular events. Diabex Duo may be used alone or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual health status, blood sugar readings, and other concurrent medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the risk of future complications. Continued adherence to the prescribed diet and exercise plan is vital. Lifestyle modifications significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; proper recognition and management of hypoglycemia are essential. This medication isn't suitable for all patients. Prior to use, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should consult their doctor. Interactions with other medications are possible; disclose all medications to your physician to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Eveglip-M Tablet

The provided text is "undefined," therefore no rewriting is possible.

Uses of Eveglip-M Tablet

Managing type 2 diabetes

Major Benefits of Eveglip-M Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eveglip-M Tablet with a meal.

Common Side effects of Eveglip-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Eveglip-M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eveglip-M Tablet with a meal.

How Eveglip-M Tablet works:

Metformin and glimepiride are combined in Eveglip-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Eveglip-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Eveglip-M Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Eveglip-M Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Eveglip-M Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

LiverLiverUNSAFE

Use of Eveglip-M Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical counsel.

What if you forget to take Eveglip-M Tablet :

Should you forget to take your Eveglip-M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Eveglip-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Eveglip-M Tablet

Eveglip-M Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Eveglip-M Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always discuss taking other medications with your doctor.
Eveglip-M Tablets are contraindicated in patients allergic to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Eveglip-M Tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Eveglip-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Eveglip-M and seek immediate medical attention.
Prolonged Eveglip-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Eveglip-M Tablet as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Eveglip-M Tablet
53
MRP 65
18% off